FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2809848767> ?p ?o ?g. }

• W2809848767 endingPage "259" @default.
• W2809848767 startingPage "253" @default.
• W2809848767 abstract "Background Rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are common disorders associated with increased rates of cardiovascular disease (CVD), but the contribution of cytokine-induced inflammation to impaired cardiovascular function in these conditions remains poorly understood. Objectives We assessed the effect of anti-TNF therapy on myocardial and vascular function, myocardial tissue characteristics and perfusion in inflammatory arthropathy and systemic rheumatic disease (IASRD) patients, using cardiovascular magnetic resonance (CMR). Methods 20 RA patients, 7 AS patients, 5 PsA patients without previously known CVD scheduled to commence anti-TNF therapy and 8 RA patients on standard disease modifying antirheumatic drugs underwent CMR at 1.5 T, including cine, tagging, pulse wave velocity (PWV), T2-weighted, native and postcontrast T1 mapping, ECV quantification, rest and stress perfusion and late gadolinium enhancement (LGE) imaging. Results Following anti-TNF therapy, there was significant reversal of baseline subclinical cardiovascular dysfunction, as evidenced by improvement in peak systolic circumferential strain (p < 0.001), peak diastolic circumferential strain rate (p < 0.001), and total aortic PWV, (p < 0.001). This was accompanied by a reduction in myocardial inflammation, as assessed by T2-weighted imaging (p = 0.005), native T1 mapping (p = 0.009) and ECV quantification (p = 0.001), as well as in serum inflammatory markers like CRP (p < 0.001) and ESR (p < 0.001), and clinical measures of disease activity (DAS28-CRP, p = 0.001; BASDAI, p < 0.001). A trend towards improvement in myocardial perfusion was observed (p = 0.07). Focal myocardial fibrosis, as detected by LGE CMR was not altered by anti-TNF therapy (p = 0.92). Conclusions Anti-TNF therapy reduces subclinical myocardial inflammation and improves cardiovascular function in RA, AS and PsA. CMR may be used to track disease progression and response to therapy. Future CMR-based studies to demonstrate effect of anti-TNF therapy modulation of vascular structure and function on hard clinical events and outcomes would be useful." @default.
• W2809848767 created "2018-07-10" @default.
• W2809848767 creator A5001277622 @default.
• W2809848767 creator A5006325368 @default.
• W2809848767 creator A5028238617 @default.
• W2809848767 creator A5046495749 @default.
• W2809848767 creator A5057713351 @default.
• W2809848767 creator A5061305020 @default.
• W2809848767 creator A5068034242 @default.
• W2809848767 creator A5070529061 @default.
• W2809848767 creator A5076713788 @default.
• W2809848767 creator A5078328047 @default.
• W2809848767 creator A5090640809 @default.
• W2809848767 date "2018-11-01" @default.
• W2809848767 modified "2023-10-10" @default.
• W2809848767 title "Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases" @default.
• W2809848767 cites W127633853 @default.
• W2809848767 cites W1568240553 @default.
• W2809848767 cites W1911773670 @default.
• W2809848767 cites W1942793553 @default.
• W2809848767 cites W1967501597 @default.
• W2809848767 cites W1984641211 @default.
• W2809848767 cites W1997688652 @default.
• W2809848767 cites W2006508437 @default.
• W2809848767 cites W2015646727 @default.
• W2809848767 cites W2016186074 @default.
• W2809848767 cites W2018760896 @default.
• W2809848767 cites W2021794274 @default.
• W2809848767 cites W2026865649 @default.
• W2809848767 cites W2039077567 @default.
• W2809848767 cites W2045284061 @default.
• W2809848767 cites W2046628605 @default.
• W2809848767 cites W2052368532 @default.
• W2809848767 cites W2068985697 @default.
• W2809848767 cites W2075119261 @default.
• W2809848767 cites W2075619622 @default.
• W2809848767 cites W2078940276 @default.
• W2809848767 cites W2079148993 @default.
• W2809848767 cites W2087940953 @default.
• W2809848767 cites W2099341021 @default.
• W2809848767 cites W2100721644 @default.
• W2809848767 cites W2101420478 @default.
• W2809848767 cites W2102935782 @default.
• W2809848767 cites W2103187999 @default.
• W2809848767 cites W2112191043 @default.
• W2809848767 cites W2114947140 @default.
• W2809848767 cites W2120480222 @default.
• W2809848767 cites W2125500890 @default.
• W2809848767 cites W2129047977 @default.
• W2809848767 cites W2147155927 @default.
• W2809848767 cites W2156252910 @default.
• W2809848767 cites W2159513257 @default.
• W2809848767 cites W2407777047 @default.
• W2809848767 cites W410817826 @default.
• W2809848767 cites W4237863175 @default.
• W2809848767 cites W4313347683 @default.
• W2809848767 doi "https://doi.org/10.1016/j.ijcard.2018.06.099" @default.
• W2809848767 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30017519" @default.
• W2809848767 hasPublicationYear "2018" @default.
• W2809848767 type Work @default.
• W2809848767 sameAs 2809848767 @default.
• W2809848767 citedByCount "43" @default.
• W2809848767 countsByYear W28098487672018 @default.
• W2809848767 countsByYear W28098487672019 @default.
• W2809848767 countsByYear W28098487672020 @default.
• W2809848767 countsByYear W28098487672021 @default.
• W2809848767 countsByYear W28098487672022 @default.
• W2809848767 countsByYear W28098487672023 @default.
• W2809848767 crossrefType "journal-article" @default.
• W2809848767 hasAuthorship W2809848767A5001277622 @default.
• W2809848767 hasAuthorship W2809848767A5006325368 @default.
• W2809848767 hasAuthorship W2809848767A5028238617 @default.
• W2809848767 hasAuthorship W2809848767A5046495749 @default.
• W2809848767 hasAuthorship W2809848767A5057713351 @default.
• W2809848767 hasAuthorship W2809848767A5061305020 @default.
• W2809848767 hasAuthorship W2809848767A5068034242 @default.
• W2809848767 hasAuthorship W2809848767A5070529061 @default.
• W2809848767 hasAuthorship W2809848767A5076713788 @default.
• W2809848767 hasAuthorship W2809848767A5078328047 @default.
• W2809848767 hasAuthorship W2809848767A5090640809 @default.
• W2809848767 hasConcept C126322002 @default.
• W2809848767 hasConcept C146957229 @default.
• W2809848767 hasConcept C164705383 @default.
• W2809848767 hasConcept C2776252253 @default.
• W2809848767 hasConcept C2776260265 @default.
• W2809848767 hasConcept C2776914184 @default.
• W2809848767 hasConcept C2777402515 @default.
• W2809848767 hasConcept C2777453003 @default.
• W2809848767 hasConcept C2777575956 @default.
• W2809848767 hasConcept C2778319312 @default.
• W2809848767 hasConcept C71924100 @default.
• W2809848767 hasConcept C84393581 @default.
• W2809848767 hasConceptScore W2809848767C126322002 @default.
• W2809848767 hasConceptScore W2809848767C146957229 @default.
• W2809848767 hasConceptScore W2809848767C164705383 @default.
• W2809848767 hasConceptScore W2809848767C2776252253 @default.
• W2809848767 hasConceptScore W2809848767C2776260265 @default.
• W2809848767 hasConceptScore W2809848767C2776914184 @default.

• next